Meta BioMed and Solmedix Join Forces to Target the Global Biodegradable Medical Device Market

Meta BioMed, a company specializing in high-performance biomedical materials, is accelerating its efforts to penetrate the global medical device market in partnership with Solmedix, a leading medical device development company.

Representatives of Meta BioMed and Solmedics are taking a commemorative photo for their strategic partnership. Meta BioMed

On September 17, Meta BioMed announced that it has entered into a strategic alliance with Solmedix to target the biodegradable medical device market.

The key focus of this partnership is to establish a collaborative system that connects 'materials–joint development–commercialization–business expansion' by combining Meta BioMed’s expertise in biodegradable polymer material technology and global business networks with Solmedix’s capabilities in medical device research, development, and manufacturing.

Meta BioMed will first target the market for biodegradable implants in orthopedics and sports medicine. One of Solmedix’s primary products, “Quratus,” is a medical device based on biodegradable polymer materials, used for procedures such as rotator cuff repair surgeries. The device is designed to fix and support soft tissues like damaged ligaments and tendons to bone, then gradually decomposes within the body over a certain period.

Building on this, the two companies plan to jointly develop new medical devices utilizing biodegradable polymer materials and to expand the application scope to various medical device sectors, beginning with orthopedics.

Moving forward, both parties intend to pursue the joint development and commercialization of biodegradable medical devices in phases, and will also consider additional investments and the expansion of joint business activities depending on project progress.

Jisoo Oh, CEO of Meta BioMed, commented, “Our strategic alliance with Solmedix is an important milestone in expanding our accumulated biodegradable polymer materials technology into the high value-added medical device field. We plan to broaden our partnership from joint development to overseas market entry and CDMO operations, cultivating biopolymers as a new growth axis and strengthening our competitiveness in the global biodegradable medical device market.”

This content was produced with the assistance of AI translation services.